The AI tool merges dunnhumby’s Retailer Preference Index with Placer.ai’s geolocation data to maintain actionable knowledge about a retailer’s competitive threat.
Xifaxan 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea in adults.